The purpose of this work is to investigate the feasibility of spatio-temporal generalized Model Observer methods for protocol optimization programs in the field of interventional radiography. Two Model Observers were taken under examination: a Channelized Hotelling Observer with 24 spatio-temporal Gabor channels and a Non Pre-Whitening Model Observer with two different implementations of the spatio-temporal contrast sensitivity function. The images of targets, both stationary and in motion, were acquired in fluoroscopic mode using a CDRAD phantom for signal-present images and an homogenous slab of PMMA for signal-absent ones. After the processing, these images were used to build three series of two alternative forced choice experiments, designed to simulate tasks of clinical interest, and submitted to three human observers in order to set a goal on detectability. A first set of images was used for model tuning and subsequently the verified models were validated throughout a second set of images. Results from the validation phase, for both models, show good agreement with the human observer performances (Root Mean Square Error RMSE ≤ 12%). The tuning phase emerges as a crucial step in building models for angiographic dynamic images; the final agreement underlines the good capability of these spatio-temporal models in simulating human performances, allowing to consider them as a useful and worthwhile tool in protocol optimization when dynamic images are involved.
The most widely used method in Europe to estimate breast dosimetry in mammography is based on Dance's publications. Recently, AAPM and EFOMP joint Task Group 282 (TG282) has published a new breast dosimetry model, which improves the accuracy in Average Glandular Dose (AGD) estimation. This multicentre study aims to evaluate variations in AGD between conventional and new dosimetry across different modalities and mammography systems. Measurements were conducted on 74 mammography systems from six vendors, installed in hospitals across Italy. Each facility used its own equipment while adhering to the same protocol and spreadsheets. Tube output and Half-Value Layer (HVL) were measured in the two configurations for Digital Mammography (DM), Digital Breast Tomosynthesis (DBT), and Contrast-Enhanced Mammography (CEM). Exposures were performed using a breast-shaped PMMA phantom of different thicknesses. Data were centrally collected to compute AGD using appropriate correction factors for conventional dosimetry and the BreastAGD282 software for TG282 dosimetry, using EU legacy model. The sample allows for the identification of typical AGD values for both methodologies. The study highlights a reduction in median AGD with the new dosimetry model compared to Dance method across all modalities and vendors. Furthermore, the reduction magnitude depends on x-ray beam quality, modality and compressed breast thickness, ranging from 6.1-8.4 % at 21 mm to 27.3-38.3 % at 90 mm. The new TG282 dosimetry model showed a reduction in the estimated median AGD. Notably, the magnitude of this reduction depended on x-ray beam quality, modality and compressed breast thickness.
Myeloablative Total Body Irradiation (TBI) used in our Institution, as part of the conditioning scheme for haematopoietic stem cell transplantation, is an extended-distance supine technique that has been implemented using a 15 MV LINAC beam, lead lung compensators, PMMA, and water bolus to improve homogeneity. This study reviews in-vivo dosimetry (IVD) over 10 years of treatments, assessing the technique's robustness, accuracy, and efficiency. A 2-lateral opposite fields plan was calculated from planning CT with validated Oncentra TPS (Elekta AB, Sweden). Monitor units (MUs), lung compensators shape and thickness were calculated to deliver the prescription dose (12 Gy in 6 bi-daily fractions or 9.9 Gy in 3 daily fractions) to the patient's abdomen midline at the umbilical level, maintaining lung dose within ±5 % range of prescription. Data from 103 patients, of which more than 87 % were pediatric, were retrieved and analyzed for a total of 537 treatment fractions. The impact of IVD omission was evaluated, supposing doing it only once or in the first two fractions, if necessary. Median ΔMU from planned was -1.2 %. Median percentage dose deviation from prescription in 6 anatomical regions was below 2 %. IVD omission could have resulted in an increase of 7 patients registering at least one anatomical region outside the ±5 % dose range at the end of treatment. It is possible to confirm the implemented technique's robustness and accuracy in delivering the prescribed dose under IVD monitoring. Nevertheless, this technique and associated IVD are time-consuming and IVD omission could be assessed with limited drawbacks.
7 July 2026 in Journal of Imaging Informatics in Medicine